Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy-Reference-Cited by-同舟云学术

Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy

Published:2008-02 Issue:2 Volume:108 Page:421-427
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bamias Aristotelis,Koutsoukou Vasiliki,Terpos Evangelos,Tsiatas Marinos L.,Liakos Christina,Tsitsilonis Ourania,Rodolakis Alexandros,Voulgaris Zannis,Vlahos G.,Papageorgiou Theocharis,Papatheodoridis G.,Archimandritis A.,Antsaklis A.,Dimopoulos M.A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference46 articles.

1. Cancer statistics 2003;Jemal;CA Cancer J Clin,2003

2. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols;J Clin Oncol,2003

3. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;du Bois;J Natl Cancer Inst,2003

4. Management of advanced ovarian cancer consensus summary;Ozols;Semin Oncol,2000

5. Ovarian cancer: epidemiology, biology, and prognostic factors;Holschneider;Semin Surg Oncol,2000

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma;Nature Communications;2024-07-16

2. Oncogenic Pathways and Targeted Therapies in Ovarian Cancer;Biomolecules;2024-05-15

3. The deregulation of arachidonic acid metabolism in ovarian cancer;Frontiers in Oncology;2024-05-02

4. Malignant ascites: Current therapy options and treatment prospects;Cancer Treatment Reviews;2023-12

5. Improving targeted small molecule drugs to overcome chemotherapy resistance;Cancer Reports;2023-11-22